ZyPREXA 10 mg Injection
RxNorm 545353
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 545353 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ZyPREXA 10 mg Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Olanzapine 10 mg Injection [Zyprexa]
(Atom ID: 7704453)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
OLANZapine 10 mg Injection [ZyPREXA]
(Atom ID: 7705876)
PSNPrescribable
Prescribable Name (PSN):
ZyPREXA 10 mg Injection
(Atom ID: 7704454)
SYPrescribable
Synonym (SY):
Zyprexa 10 mg Injection
(Atom ID: 7704455)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ZyPREXA 10 mg Injection
(Atom ID: 7705857)
Patient Education
Olanzapine Injection
Olanzapine extended-release injection is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Olanzapine injection is used to treat episodes of agitation in people who have schizophrenia or in people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods) and are experiencing an episode of mania (abnormally excited or irritated mood). Olanzapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.